Robocath receives an additional €1.25 million financial contribution from Crédit Agricole Innovations et Territoires (CAIT), an innovation fund managed by Supernova Invest. In line with the company’s growth strategy, the new funding aims to increase the resources available to market the R-OneTM product and launch the development of the next generation of […]
Neuro
InspireMD Announces Expansion of its Distribution Network for CGuard™ EPS in Australia, New Zealand and Vietnam
TEL AVIV, lSRAEL, Dec. 04, 2017 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed Diverse Devices Pty Ltd as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production […]
EndoVantage Secures 510(k) Clearance from FDA for SurgicalPreviewTM
SCOTTSDALE, AZ – November 8, 2017 – EndoVantage, LLC, a pioneer in cloud-based medical simulation technology, today announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration for SurgicalPreviewTM, its preoperative planning system for the endovascular treatment of cerebral aneurysms. A cerebral aneurysm is a weak spot […]
MRI Interventions’ ClearPoint® NeuroNavigation System Achieves 2000th Procedure Milestone
IRVINE, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced the 2000th procedure completed with the ClearPoint NeuroNavigation System. The procedure was done by Dr. William Anderson at Johns Hopkins University. In the fall of 1998, a group of researchers at Johns Hopkins University imagined a novel […]
Stryker Announces Publication of the DAWN Trial Results in the New England Journal of Medicine
KALAMAZOO, Michigan, USA, Nov. 13, 2017 /PRNewswire/ — The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from an ischemic stroke receives thrombectomy, […]
FDA Approves Stryker’s Neuroform Atlas Stent System to Treat Wide Neck Aneurysms
KALAMAZOO, Michigan, USA, Nov. 9, 2017 /PRNewswire/ — Stryker Corporation announced today that the U.S. Food and Drug Administration has approved the Neuroform Atlas™ Stent System for marketing under a humanitarian device exemption (HDE). The device is to be utilized in conjunction with neurovascular embolic coils for the treatment of wide neck, […]
Vesalio Announces NeVa™ Stroke Treatment Product CE Mark Certification
Nashville, TN, October 31, 2017 –(PR.com)– Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa™ neurothrombectomy platform for the treatment of strokes. Developed by a team of physicians that treat stroke, the NeVa mechanical thrombectomy technology was designed to improve “first pass” success, by effectively […]
InspireMD’s CGuard Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in Poland
TEL AVIV, ISRAEL — (Marketwired) — Oct 25, 2017 — InspireMD (NYSE MKT:NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR) (NYSE American: NSPR.WS), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that Prof. Waclaw Kuczmik, Head of the Vascular Surgery Department of Katowice Clinical Hospital N […]
Sub-Lite-Wall® StreamLiner™ Series Poised to Become New Design Standard for Improved Access in Catheter Delivery
ORANGEBURG, S.C., Oct. 24, 2017 /PRNewswire/ — Zeus Industrial Products Inc. (“Zeus”) has released its latest thin-walled PTFE catheter liner as part of their Sub-Lite-Wall® StreamLiner™ series. StreamLiner™ XT, the first offering from the series, was released in July with an impressive maximum wall thickness of 0.00075″ (0.01905 mm). The next in the series, […]
InspireMD Announces The Start Of Patient Enrollment In An Investigator Initiated Trial Of Cguard EPS In Russia
TEL AVIV, ISRAEL–(Marketwired – October 09, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR), a leader in Embolic Prevention Systems (EPS) / thrombus management technologies and neurovascular devices, today announced the start of patient enrollment in an investigator initiated trial in Russia, entitled: Independent Randomized Trial in Carotid Artery Revascularization Comparing […]